By enrolling owned animals and assessing owner-reported and clinic-based outcomes, the study design supports direct translational relevance to small-animal practice, according to an Akston press release. In the release, Akston reports preclinical data from laboratory cats at Cornell indicating reductions in voluntary food intake without adverse effects or unanticipated events. The company stated that pharmacokinetic analysis supported once-weekly dosing in these studies
With the sharply reduced appetite on Zepbound, it helps to deliberately prioritize protein-rich foods and, where needed, protein shakes
Rashmi Roy, one of the nations highest-volume thyroid surgeons, for an insightful conversation on thyroid cancer risk, diagnosis, and treatment
Prepare in Advance: Have your injection supplies ready the day before
"FDA Approves Levoleucovorin"